Background Although cross-sectional studies have shown that leukocyte is linked with metabolic syndrome (MetS), few longitudinal or cohort studies have been used to confirm this relationship. We therefore conducted a large-scale health check-up longitudinal cohort in urban Chinese population from middle to upper socioeconomic strata to investigate and prove the association between the total leukocyte/its subtypes and MetS/its components (obesity, hyperglycemia, dyslipidemia, and hypertension). Methods A longitudinal cohort study was established in 2005 on individuals who were middle-to-upper class urban Chinese. Data used in this investigation was based on 6,513 participants who had at least three routine health check-ups over a period of six-year follow-up. Data analysis was conducted through generalized estimating equation (GEE) model. Results A total of 255 cases of MetS occurred over the six-year follow-up, leading to a total incidence density of 11.45 per 1,000 person-years (255/22279 person-years). The total leukocyte was markedly associated with MetS (RR = 2.66, 95%CI = 1.81–3.90], p<0.0001) and a dose-response existed. Similar trends can be found in monocytes, lymphocytes, and neutrophils compared with the total leukocyte. The total leukocyte, neutrophil, monocyte and eosinophil levels were strong and independent risk factors to obesity, total leukocyte and neutrophil to dyslipidemia and hyperglycemia, while neither total leukocyte nor its subtypes to hypertension. Conclusion Total leukocyte/its subtype were associated with MetS/its components (obesity, dyslipidemia and hyperglycemia), they might provide convenient and useful markers for further risk appraisal of MetS, and be the earlier biomarkers for predicting cardiovascular disease than the components of MetS.
Janszky I, Vatten L, Romundstad P, Laugsand LE, Bjorngard JH, et al.. (2011) Metabolic syndrome in Poland – the PONS Study. Ann Agric Environ Med 18: 270–272. 972483 [pii].
[4]
Szigethy E, Szeles G, Horvath A, Hidvegi T, Jermendy G, et al.. (2012) Epidemiology of the metabolic syndrome in Hungary. Public Health 126: 143–149. S0033-3506(11)00339-8 [pii];10.1016/j.puhe.2011.11.003 [doi].
[5]
Cuevas A, Alvarez V, Carrasco F (2011) Epidemic of metabolic syndrome in Latin America. Curr Opin Endocrinol Diabetes Obes 18: 134–138. 10.1097/MED.0b013e3283449167 [doi].
[6]
McCullough AJ (2011) Epidemiology of the metabolic syndrome in the USA. J Dig Dis 12: 333–340. 10.1111/j.1751-2980.2010.00469.x [doi].
[7]
Li JB, Wang X, Zhang JX, Gu P, Zhang X, et al. (2010) Metabolic syndrome: prevalence and risk factors in southern China. J Int Med Res 38: 1142–1148.
[8]
Oda E (2008) The metabolic syndrome as a concept of adipose tissue disease. Hypertens Res 31: 1283–1291. JST.JSTAGE/hypres/31.1283 [pii];10.1291/hypres.31.1283 [doi].
[9]
Dandona P, Aljada A, Chaudhuri A, Mohanty P, Garg R (2005) Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation 111: 1448–1454. 111/11/1448 [pii];10.1161/01.CIR.0000158483.13093.9D [doi].
[10]
Zuliani G, Volpato S, Galvani M, Ble A, Bandinelli S, et al.. (2009) Elevated C-reactive protein levels and metabolic syndrome in the elderly: The role of central obesity data from the InChianti study. Atherosclerosis 203: 626–632. S0021-9150(08)00541-8 [pii];10.1016/j.atherosclerosis.2008.07.？038[doi].
[11]
Tamakoshi K, Yatsuya H, Kondo T, Hori Y, Ishikawa M, et al.. (2003) The metabolic syndrome is associated with elevated circulating C-reactive protein in healthy reference range, a systemic low-grade inflammatory state. Int J Obes Relat Metab Disord 27: 443–449. 10.1038/sj.ijo.0802260 [doi];0802260 [pii].
[12]
Frohlich M, Imhof A, Berg G, Hutchinson WL, Pepys MB, et al. (2000) Association between C-reactive protein and features of the metabolic syndrome: a population-based study. Diabetes Care 23: 1835–1839.
[13]
Mahajan A, Jaiswal A, Tabassum R, Podder A, Ghosh S, et al.. (2012) Elevated levels of C-reactive protein as a risk factor for metabolic syndrome in Indians. Atherosclerosis 220: 275–281. S0021-9150(11)01021-5 [pii];10.1016/j.atherosclerosis.2011.10.？031[doi].
[14]
Belfki H, Ben AS, Bougatef S, Ben AD, Haddad N, et al.. (2012) Relationship of C-reactive protein with components of the metabolic syndrome in a Tunisian population. Eur J Intern Med 23: e5-e9. S0953-6205(11)00243-3 [pii];10.1016/j.ejim.2011.10.011 [doi].
[15]
Sesso HD, Buring JE, Rifai N, Blake GJ, Gaziano JM, et al.. (2003) C-reactive protein and the risk of developing hypertension. JAMA 290: 2945–2951. 10.1001/jama.290.22.2945 [doi];290/22/2945 [pii].
[16]
Oda E, Kawai R (2010) Comparison between high-sensitivity C-reactive protein (hs-CRP) and white blood cell count (WBC) as an inflammatory component of metabolic syndrome in Japanese. Intern Med 49: 117–124. JST.JSTAGE/internalmedicine/49.2670 [pii].
[17]
Park JT, Chang TI, Kim DK, Choi HY, Lee JE, et al.. (2009) Association of white blood cell count with metabolic syndrome in patients undergoing peritoneal dialysis. Metabolism 58: 1379–1385. S0026-0495(09)00164-4 [pii];10.1016/j.metabol.2009.05.002 [doi].
[18]
Nakanishi N, Suzuki K, Tatara K (2002) White blood cell count and clustered features of metabolic syndrome in Japanese male office workers. Occup Med (Lond) 52: 213–218.
[19]
Fan X, Liu EY, Freudenreich O, Park JH, Liu D, et al.. (2010) Higher white blood cell counts are associated with an increased risk for metabolic syndrome and more severe psychopathology in non-diabetic patients with schizophrenia. Schizophr Res 118: 211–217. S0920-9964(10)01114-X [pii];10.1016/j.schres.2010.02.1028 [doi].
[20]
Wu CZ, Hsiao FC, Lin JD, Su CC, Wang KS, et al.. (2010) Relationship between white blood cell count and components of metabolic syndrome among young adolescents. Acta Diabetol 47: 65–71. 10.1007/s00592-009-0101-z [doi].
[21]
Lee YJ, Shin YH, Kim JK, Shim JY, Kang DR, et al.. (2010) Metabolic syndrome and its association with white blood cell count in children and adolescents in Korea: the 2005 Korean National Health and Nutrition Examination Survey. Nutr Metab Cardiovasc Dis 20: 165–172. S0939-4753(09)00072-6 [pii];10.1016/j.numecd.2009.03.017 [doi].
[22]
Oda E, Kawai R (2009) The prevalence of metabolic syndrome and diabetes increases through the quartiles of white blood cell count in Japanese men and women. Intern Med 48: 1127–1134. JST.JSTAGE/internalmedicine/48.2138 [pii].
[23]
Kim JA, Choi YS, Hong JI, Kim SH, Jung HH, et al.. (2006) Association of metabolic syndrome with white blood cell subtype and red blood cells. Endocr J 53: 133–139. JST.JSTAGE/endocrj/53.133 [pii].
[24]
Chen W, Srinivasan SR, Xu J, Berenson GS (2010) Black-white divergence in the relation of white blood cell count to metabolic syndrome in preadolescents, adolescents, and young adults: the Bogalusa Heart Study. Diabetes Care 33: 2474–2476. dc10-0619 [pii];10.2337/dc10-0619 [doi].
[25]
Lao XQ, Neil TG, Jiang C, Zhang W, Adab P, et al.. (2008) White blood cell count and the metabolic syndrome in older Chinese: the Guang zhou Biobank Cohort Study. Atherosclerosis 201: 418–424. S0021-9150 (08) 00017-8 [pii];10.1016/j.atherosclerosis.2007.12.？053[doi].
[26]
Odagiri K, Uehara A, Mizuta I, Yamamoto M, Kurata C (2011) Longitudinal study on white blood cell count and the incidence of metabolic syndrome. Intern Med 50: 2491–2498. JST.JSTAGE/internalmedicine/50.5877 [pii].
[27]
Zeger SL, Liang KY (1986) Longitudinal data analysis for discrete and continuous outcomes. Biometrics 42: 121–130.
[28]
Lu YH, Lu JM, Wang SY, Li CL, Liu LS, et al. (2006) [Comparison of the diagnostic criteria of metabolic syndrome by International Diabetes Federation and that by Chinese Medical Association Diabetes Branch]. Zhonghua Yi Xue Za Zhi 86: 386–389.
[29]
Schafer JL (1999) Multiple imputation: a primer. Stat Methods Med Res 8: 3–15.
[30]
Rochon J (1998) Application of GEE procedures for sample size calculations in repeated measures experiments. Stat Med 17: 1643–1658. 10.1002/(SICI)1097-0258(19980730)17:14<1？643:AID-SIM869>3.0.CO;2–3 [pii].
[31]
Lee JH, Herzog TA, Meade CD, Webb MS, Brandon TH (2007) The use of GEE for analyzing longitudinal binomial data: a primer using data from a tobacco intervention. Addict Behav 32: 187–193. S0306-4603(06)00101-8 [pii];10.1016/j.addbeh.2006.03.030 [doi].
[32]
Hubbard AE, Ahern J, Fleischer NL, Van der Laan M, Lippman SA, et al.. (2010) To GEE or not to GEE: comparing population average and mixed models for estimating the associations between neighborhood risk factors and health. Epidemiology 21: 467–474. 10.1097/EDE.0b013e3181caeb90 [doi].
[33]
Lin KC, Chen YJ, Shyr Y (2008) A nonparametric smoothing method for assessing GEE models with longitudinal binary data. Stat Med 27: 4428–4439. 10.1002/sim.3315 [doi].
[34]
Nakanishi N, Sato M, Shirai K, Nakajima K, Murakami S, et al. (2002) Associations between white blood cell count and features of the metabolic syndrome in Japanese male office workers. Ind Health 40: 273–277.
[35]
Wu CZ, Lin JD, Li JC, Kuo SW, Hsieh CH, et al.. (2009) Association between white blood cell count and components of metabolic syndrome. Pediatr Int 51: 14–18. PED2658 [pii];10.1111/j.1442-200X.2008.02658.x [doi].
[36]
Kitabchi AE, Temprosa M, Knowler WC, Kahn SE, Fowler SE, et al.. (2005) Role of insulin secretion and sensitivity in the evolution of type 2 diabetes in the diabetes prevention program: effects of lifestyle intervention and metformin. Diabetes 54: 2404–2414. 54/8/2404 [pii].
[37]
Razani B, Chakravarthy MV, Semenkovich CF (2008) Insulin resistance and atherosclerosis. Endocrinol Metab Clin North Am 37: 603–21, viii. S0889-8529(08)00029-7 [pii];10.1016/j.ecl.2008.05.001 [doi].
[38]
Fernandez-Real JM, Ricart W (1999) Insulin resistance and inflammation in an evolutionary perspective: the contribution of cytokine genotype/phenotype to thriftiness. Diabetologia 42: 1367–1374. 90421367.125 [pii];10.1007/s001250051451 [doi].
[39]
Fernandez-Real JM, Broch M, Vendrell J, Ricart W (2003) Insulin resistance, inflammation, and serum fatty acid composition. Diabetes Care 26: 1362–1368.
[40]
Hagita S, Osaka M, Shimokado K, Yoshida M (2011) Adipose inflammation initiates recruitment of leukocytes to mouse femoral artery: role of adipo-vascular axis in chronic inflammation. PLoS One 6: e19871. 10.1371/journal.pone.0019871 [doi]; PONE-D-11-01219 [pii].
[41]
Kawanishi N, Yano H, Yokogawa Y, Suzuki K (2010) Exercise training inhibits inflammation in adipose tissue via both suppression of macrophage infiltration and acceleration of phenotypic switching from M1 to M2 macrophages in high-fat-diet-induced obese mice. Exerc Immunol Rev 16: 105–118.
[42]
Ohashi K, Parker JL, Ouchi N, Higuchi A, Vita JA, et al.. (2010) Adiponectin promotes macrophage polarization toward an anti-inflammatory phenotype. J Biol Chem 285: 6153–6160. M109.088708 [pii];10.1074/jbc.M109.088708 [doi].
[43]
Li K, Xu W, Guo Q, Jiang Z, Wang P, et al.. (2009) Differential macrophage polarization in male and female BALB/c mice infected with coxsackievirus B3 defines susceptibility to viral myocarditis. Circ Res 105: 353–364. CIRCRESAHA.109.195230 [pii];10.1161/CIRCRESAHA.109.195230 [doi].
[44]
Mohamed-Ali V, Goodrick S, Rawesh A, Katz DR, Miles JM, et al. (1997) Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J Clin Endocrinol Metab 82: 4196–4200.
[45]
Benagiano M, Azzurri A, Ciervo A, Amedei A, Tamburini C, et al.. (2003) T helper type 1 lymphocytes drive inflammation in human atherosclerotic lesions. Proc Natl Acad Sci U S A 100: 6658–6663. 10.1073/pnas.1135726100 [doi];1135726100 [pii].
[46]
Wang YY, Lin SY, Liu PH, Cheung BM, Lai WA (2004) Association between hematological parameters and metabolic syndrome components in a Chinese population. J Diabetes Complications 18: 322–327. S1056872704000030 [pii];10.1016/S1056-8727(04)00003-0 [doi].
[47]
Fried SK, Bunkin DA, Greenberg AS (1998) Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J Clin Endocrinol Metab 83: 847–850.
[48]
Halle M, Berg A, Northoff H, Keul J (1998) Importance of TNF-alpha and leptin in obesity and insulin resistance: a hypothesis on the impact of physical exercise. Exerc Immunol Rev 4: 77–94.
